NBIX

Neurocrine Biosciences
D

NBIX

94.930
USD
-7.98
(-7.75%)
مغلق
حجم التداول
69,913
الربح لكل سهم
5
العائد الربحي
-
P/E
29
حجم السوق
9,452,891,395
أصول ذات صلة
ALNY
ALNY
-21.680
(-8.26%)
240.730 USD
AMGN
AMGN
-13.59
(-4.38%)
294.28 USD
A
ARWR
-1.220
(-10.11%)
10.850 USD
BIIB
BIIB
-6.460
(-4.94%)
124.230 USD
GILD
GILD
-3.990
(-3.55%)
108.390 USD
ILMN
ILMN
-2.720
(-3.56%)
73.650 USD
REGN
REGN
-32.25
(-5.28%)
578.63 USD
S
SGMO
0.03970
(6.40%)
0.65980 USD
S
SRPT
-3.990
(-6.80%)
54.680 USD
VRTX
VRTX
-7.25
(-1.50%)
474.69 USD
المزيد
الأخبار المقالات

العنوان: Neurocrine Biosciences

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.